All of these findings highlight the contributions of this study, as this new scale provides a clinical tool to be used in clinical practice for the exploration of visual anomalies. To the best of our knowledge, no other similar questionnaire can be compared with the SQVD. There is a novel scale for schoolchildren with nonstrabismic binocular vision anomalies,
27 but it is designed to quantify quality of life. Even though it has several items that ask about visual symptoms, the goal of the tool is to measure quality of life in a pediatric population, thus comparison with the SQVD would be difficult. The Conlon questionnaire
7 was developed to quantify visual discomfort, but its description of visual discomfort is neither related nor comparable to symptoms associated with visual dysfunction. Items in the Conlon survey include several symptoms within the same question, which makes it difficult to compare this instrument with other scales. In any case, it does have several questions that are similar to some SQVD items, such as those about headache, blurred vision, ocular irritation, and reading problems. Again, when comparing the SQVD with the CISS survey,
9 symptoms related to headache, blurred vision, red eyes, the need to reread the text, and sleepy feeling are common to both questionnaires. This could suggest that the CISS could be used to evaluate symptoms due to any type of visual anomaly; however, it was developed for convergence insufficiency only. Although a cross-cultural adaptation for the Spanish language has been made using the Rasch method,
52 the original questionnaire
9 was not validated using this method. Several authors have used the CISS for other visual dysfunctions,
53–56 but this is not an appropriate approach because a questionnaire should only be used for the specific condition for which it was developed and validated.
57,58 In fact, other studies in the literature have reported difficulties when applying the CISS to other visual conditions, different from convergence insufficiency.
59–61